On ECHEMI

Alpha Biopharmaceuticals Co., Ltd.

/
Favorite Supplier
 371 people visit

Product List

Product Name Synonyms CAS No. Grate/Content Operate

(D-Ala1)-Peptide T amide

DAPTA;Adaptavir;106362-34-9;(D-Ala1)-peptide T amide;D-Ala-peptide T-amide;UNII-J208V4ZMP2;RAP101;J208V4ZMP2;L-Threoninamide, D-alanyl-L-seryl-L-threonyl-L-threonyl-L-threonyl-L-asparaginyl-L-tyrosyl-;H-D-ALA-SER-THR-THR-THR-ASN-TYR-THR-NH2
106362-34-9 Inquiry

(Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH (salmon)

(DES-GLY10,D-ALA6,PRO-NHET9)-GONADOTROPIN-RELEASING HORMONE (SALMON);(DES-GLY10,D-ALA6,PRO-NHET9)-LHRH (SALMON);(DES-GLY10,D-ALA6,PRO-NHET9)-LUTEINIZING HORMONE-RELEASING FACTOR (SALMON);(DES-GLY10,D-ALA6,PRO-NHET9)-LUTEINIZING HORMONE-RELEASING HORMONE (SALMON);PYR-HIS-TRP-SER-TYR-D-ALA-TRP-LEU-PRO-NHET
88848-87-7 Inquiry

(Glp1)-Apelin-13, human,bovine

[PE]APELIN-13, HUMAN, BOVINE;PYR-RPRLSHKGPMPF-OH;PYR-ARG-PRO-ARG-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE;PYR-ARG-PRO-ARG-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE-OH;[PYR1]-APELIN-13;(PYR1)-APELIN-13 (HUMAN, BOVINE);(PYR1)-APELIN-13 (HUMAN, BOVINE, MOUSE, RAT);[PGLU1]APELIN (24-36), HUMAN, BOVINE
217082-60-5 Inquiry

(Gly14)-Humanin (human)

330936-70-4;(Gly14)-Humanin (human);CHEMBL4470851;(Gly??)-Humanin (human) trifluoroacetate salt;H-Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Gly-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala-OH
330936-70-4 Inquiry

(Sar1,Ala8)-Angiotensin II

38027-95-1 Inquiry

2-[(2S,5R,8S,11S)-5-Benzyl-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid

2-[(2S,5R,8S,11S)-5-benzyl-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;Cyclo(L-arginylglycyl-L-aspartyl-D-phenylalanyl-N-methyl-L-valyl);Cilengitide;Cilengitide(EMD121974,NSC-707544);NSC 707544;Cilengitide, >=98%;Cyclo(Arg-Gly-Asp-D-Phe-N-Me-Val);c(RGDf(NMe)V)
188968-51-6 Inquiry

8-(Fmoc-Amino)-3,6-dioxaoctanoic acid

3,6,11-Trioxa-9-azadodecanoic acid,12-(9H-fluoren-9-yl)-10-oxo-;2,7,10-Trioxa-4-azadodecan-12-oic acid,1-(9H-fluoren-9-yl)-3-oxo-;12-(9H-Fluoren-9-yl)-10-oxo-3,6,11-trioxa-9-azadodecanoic acid;8-(9-Fluorenylmethoxycarbonylamino)-3,6-dioxaoctanoic acid;9-Fluorenylmethoxycarbonyl-8-amino-3,6-dioxaoctanoic acid;8-(Fmoc-amino)-3,6-dioxaoctanoic acid;[2-[2-(9H-Fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]acetic acid;Fmoc-NH-PEG2-CH2COOH;1-(9H-Fluoren-9-yl)-3-oxo-2,7,10-trioxa-4-azadodecan-12-oic acid;Fmoc-aeea;2-[2-[2-(9H-Fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]acetic acid;2-[2-[2-([[(9H-Fluoren-9-yl)methoxy]carbonyl]amino)ethoxy]ethoxy]acetic acid;1776111-66-0;2096497-78-6
166108-71-0 Inquiry

8-Amino-3,6-dioxaoctanoic acid

2-(2-(2-Aminoethoxy)ethoxy)acetic acid;H-AEEAc-OH.HCl;Amino-PEG2-CH2CO2H;Acetic acid,2-[2-(2-aminoethoxy)ethoxy]-;H2N-PEG2-CH2COOH;Amino-PEG2-acetic acid;[2-(2-Aminoethoxy)ethoxy]acetic acid;8-Amino-3,6-dioxaoctanoic acid≥ 99% (HPLC)
134978-97-5 Inquiry

8-Bromo-cAMP

8-bromoadenosine-3’,5’-cyclicmonophosphate(8-br-camp),sodiumsalt;CAMP, 8-BR, NA;ADENOSINE 3',5'-CYCLIC MONOPHOSPHATE, 8-BROMO-, SODIUM SALT;8-BROMOADENOSINE 3':5'-CYCLIC MONOPHOSPHATE SODIUM SALT;8-BROMOADENOSINE-3',5'-CYCLIC MONOPHOSPHATE SODIUM SALT;8-BROMOADENOSINE-3',5'-CYCLOPHOSPHATE SODIUM SALT;8-BROMO-CAMP, NA;8-BROMO-CAMP, SODIUM SALT
76939-46-3 Inquiry

A-779

159432-28-7;A 779;A-779;(D-Ala7)-Angiotensin I/II (1-7);CHEMBL4578721;(2R,5S,8S,11S,14S,17S,20S)-5-((1H-imidazol-4-yl)methyl)-20-amino-8-((S)-sec-butyl)-17-(3-guanidinopropyl)-11-(4-hydroxybenzyl)-14-isopropyl-2-methyl-4,7,10,13,16,19-hexaoxo-3,6,9,12,15,18-hexaazadocosanedioic acid;Ang(1-7) D-Ala7;BDBM85554;HY-P0216;BDBM50514583
159432-28-7 Inquiry

AAME hydrochloride

L-Arginine,N2-acetyl-,methyl ester,hydrochloride (1:1);L-Arginine,N2-acetyl-,methyl ester,monohydrochloride;Arginine,N2-acetyl-,methyl ester,monohydrochloride,L-;5567-53-3
1784-05-0 Inquiry

Abaloparatide

Abaloparatide;Abaloparatide (BA058)
247062-33-5 Inquiry

Abarelix acetate

PPI-149;Abarelix Acetate;Abarelix;Plenaxis;R 3827;Ac-DNal-DCpa-DPal-Ser-NαMeTyr-DAsp-Leu-Ilys-Pro-DAl-NH2;Abarelix Acetate(Plenaxis)
183552-38-7 Inquiry

Ac-Asp-Glu-Val-Asp-CHO

N-ACETYL-L-ALPHA-ASPARTYL-L-ALPHA-GLUTAMYL-N-(2-CARBOXY-1-FORMYLETHYL)-L VALINAMIDE;N-AC-ASP-GLU-VAL-ASP-CHO;N-ACETYL-ASP-GLU-VAL-ASP-AL;N-ACETYL-ASP-GLU-VAL-ASP-CHO (ALDEHYDE);ACETYL-DEVD-ALDEHYDE;ACETYL-L-ASPARTYL-L-GLUTAMYL-L-VALYL-L-ASPART-1-AL;ACETYL-ASP-GLU-VAL-ASP-ALDEHYDE;AC-DEVD-CHO
169332-60-9 Inquiry

Ac-Asp-Met-Gln-Asp-CHO

CASPASE-3 INHIBITOR IV;CASPASE 3 INHIBITOR 1;CASPASE-3 INHIBITOR (ALDEHYDE);AC-ASP-MET-GLN-ASP-ALDEHYDE;AC-ASP-MET-GLN-ASP-ALDEHYDE (PSEUDO ACID);AC-ASP-MET-GLN-ASP-CHO;AC-ASP-MET-GLN-ASP-H (ALDEHYDE);AC-DMQD-ALDEHYDE
259199-63-8 Inquiry

Ac-Calpastatin (184-210) (human)

ACETYL-CALPAIN INHIBITOR FRAGMENT (184-210) (HUMAN);ACETYL-SPERM BS-17 COMPONENT (184-210) (HUMAN);AC-CALPASTATIN (184-210) (HUMAN);AC-ASP-PRO-MET-SER-SER-THR-TYR-ILE-GLU-GLU-LEU-GLY-LYS-ARG-GLU-VAL-THR-ILE-PRO-PRO-LYS-TYR-ARG-GLU-LEU-LEU-ALA-NH2;AC-DPMSSTYIEELGKREVTIPPKYRELLA-NH2;Acetyl-Calpastatin (184-210) (huMan)Acetyl-SperM BS-17 CoMponent (184-210) (huMan), Acetyl-Calpain Inhibitor FragMent (184-210) (huMan);Acetyl-SperM BS-17 CoMponent (184-210) (huMan), Acetyl-Calpain Inhibitor FragMent (184-210) (huMan);CALPASTATIN PEPTIDE
123714-50-1 Inquiry

Ac-Leu-Glu-His-Asp-CHO

N-ACETYL-LEU-GLU-HIS-ASP-CHO (ALDEHYDE);CASPASE-9 INHIBITOR (ALDEHYDE);AC-LEU-GLU-HIS-ASP-ALDEHYDE;AC-LEU-GLU-HIS-ASP-CHO;AC-LEHD-ALDEHYDE;AC-LEHD-CHO;N-Acetyl-L-leucyl-L-alpha-glutamyl-N-[(1S)-2-carboxy-1-formylethyl]-L-histidinamide;N-Acetyl-Leu-Glu-His-Asp-al
319494-38-7 Inquiry

Ac-Pepstatin

Ac-Pepstain;Pepstatin A monoacetate (ester);N-Acetyl-Pepstatin;ACETYL-PEPSTATIN;AC-PEPSTATIN;AC-VAL-VAL-(3S,4S)-STA-ALA-(3S,4S)-STA-OH;AC-VAL-VAL-STA-ALA-STA;AC-VAL-VAL-STA-ALA-STA-OH
28575-34-0 Inquiry

Ac-Trp-Glu-His-Asp-CHO

AC-TRP-GLU-HIS-ASP-ALDEHYDE;AC-TRP-GLU-HIS-ASP-CHO;AC-TRP-GLU-HIS-ASP-H (ALDEHYDE) TRIFLUOROACETATE;AC-WEHD-ALDEHYDE;AC-WEHD-CHO;AC-WEHD-CHO TRIFLUOROACETATE;ACETYL-L-TRYPTOPHYL-L-GLUTAMYL-L-HISTIDYL-L-ASPART-1-AL-TRIFLUOROACETATE;CASPASE-INHIBITOR VIII
189275-71-6 Inquiry

Ac-Tyr-(NMe)Val-Ala-(NMe)Asp-CHO

AC-TYR-(NME)VAL-ALA-(NME)ASP-CHO;Acetyl-tyrosyl-(N-methyl)valyl-alanyl-(N-methyl)aspartal;ZINC95535609;814A903
290814-90-3 Inquiry

CONTACT INFORMATION

Send an inquiry

Product Name:
Quantity:
Shipment Term:

United States

  • China
  • Albania
  • Algeria
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Brazil
  • Brunei
  • Bulgaria
  • Burkina-faso
  • Burundi
  • Cameroon
  • Canada
  • Cape Verde
  • Cayman Islands
  • Central African
  • Chad
  • Chile
  • Colombia
  • Comoros
  • Cook Is.
  • Costa Rica
  • Croatia
  • Curacao
  • Cyprus
  • Czech
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Honduras
  • Hongkong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jordan
  • Kampuchea (Cambodia )
  • Kazakstan
  • Kenya
  • Kiribati
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macao, China
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Island
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Norfolk Island
  • North Macedonia
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Cuinea
  • Paraguay
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Republic of the Congo
  • Reunion Island
  • Romania
  • Russia
  • Rwanda
  • Saint Kitts and Nevis
  • Saint Martin
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Is
  • Somali
  • South Africa
  • South Korea
  • South Sudan
  • Spain
  • Sri Lanka
  • St.Lucia
  • Suriname
  • Swaziland
  • Sweden
  • Switzerland
  • Taiwan, China
  • Tajikstan
  • Tanzania
  • Thailand
  • The British Virgin Islands
  • The Dominican Republic
  • The Islamic Republic of Mauritania
  • The Islands of st pierre and miquelon
  • The Turks and Caicos Islands
  • Timor-Leste
  • Togo
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Tuvalu
  • Uganda
  • United Arab Emirates
  • United Kingdom
  • United States
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican
  • Vietnam
  • Wallis et Futuna
  • Western Sahara
  • Yemen
  • Zaire
  • Zambia
  • Zimbabwe
  • Afghanistan
  • Belarus
  • Cuba
  • Iran
  • Iraq
  • Libya
  • North Korea
  • Sudan
  • Syria
  • Ukraine
  • Venezuela
Message:
0/2000
Accept quotations from other qualified suppliers on ECHEMI.com

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.